New supramolecular alzheimers drugs | Chemistry World - Supramolecular chemistry could provide a new avenue in the treatment of Alzheimer’s disease, say scientists in China. The group demonstrates for the first time that supramolecular complexes can inhibit the aggregation of a peptide thought to cause Alzheimer’s disease.
(10.1039/c2sc20372c)Email Newsletter
Slinn Pickings
ChemSpy.com is owned and operated by science journalist David Bradley. Additional chemistry news updates are posted by chemist Robert Slinn CChem MRSC MPhil with the tag: Slinn Pickings.




About